La politique de l’Inde en matière de médicaments génériques

On entend souvent dire à propos de l’Inde qu’il s’agit de la « pharmacie des pays pauvres », mais qu’induit cette …

Challenging pharmaceutical patents : a « death spiral » for generic companies ?

I remain puzzled by an article in the Financial Times (1 Oct. 2010) which highlights recent doubts of the …

‘Pay for delay’ deals in the pharmaceutical industry

(Edited version, October 11, 2013) ‘Pay for delay’ deals are commonplace in the pharmaceutical industry; they involve branded drug …

Half-day conference on the commission’s pharmaceutical sector requiry

Documents Programme The EC Commission’s Sector Inquiry – Start, Provess and Provisional Findings by Philipp GASPARON Patent Litigation, Disputes …